{"gene":"GDAP1","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2005,"finding":"GDAP1 protein localizes to mitochondria, and its C-terminal transmembrane domains are necessary for correct mitochondrial localization. Missense mutations do not alter the mitochondrial localization pattern of the wild-type protein.","method":"Transient overexpression in human neuroblastoma and COS-7 cells with co-localization using organelle markers; western blot analysis of subcellular fractions with anti-GDAP1 polyclonal antibodies; C-terminal domain deletion experiments","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct subcellular fractionation plus co-localization imaging with domain deletion, replicated across multiple cell lines in the same study","pmids":["15772096"],"is_preprint":false},{"year":2009,"finding":"GDAP1 is a mitochondrial fission factor whose fission activity depends on Drp1 and Fis1. Overexpression or knockdown of wild-type GDAP1 does not influence susceptibility to apoptosis. Recessively inherited CMT mutations reduce fission activity, while dominantly inherited mutations interfere with mitochondrial fusion and increase ROS production, uneven mitochondrial transmembrane potentials, and susceptibility to apoptosis.","method":"Overexpression and knockdown experiments in cell lines; mitochondrial morphology assays; ROS measurement; apoptosis susceptibility assays; dominant-negative analysis with Drp1 and Fis1 mutants","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (morphology, ROS, apoptosis, epistasis with fission factors) in a single rigorous study","pmids":["19782751"],"is_preprint":false},{"year":2009,"finding":"GDAP1 is a tail-anchored mitochondrial outer membrane (MOM) protein. It contains a single transmembrane domain (TMD) that, together with adjacent basic amino acids, is critical for MOM targeting. The basic amino acids bordering the TMD on the cytoplasmic side are required for both MOM targeting and GDAP1-mediated fission. TMD sequence, length, and hydrophobicity per se do not influence fission function if MOM targeting is maintained.","method":"Mutagenesis of TMD and flanking basic residues combined with mitochondrial targeting assays and mitochondrial fission functional readouts in cell lines","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with defined functional readouts (targeting + fission), single lab but multiple domain variants tested","pmids":["19340293"],"is_preprint":false},{"year":2011,"finding":"Wild-type GDAP1 overexpression increases total cellular glutathione (GSH) content and mitochondrial membrane potential. GDAP1 knockdown increases susceptibility to GSH depletion-mediated oxidative stress. Fibroblasts from CMT4A patients had reduced GDAP1 levels, reduced GSH, and reduced mitochondrial membrane potential. Recessively inherited CMT mutations that reduce fission activity fail to increase GSH or mitochondrial membrane potential.","method":"Overexpression and RNAi knockdown in HT22 and NSC34 neuronal cell lines; GSH measurement assay; mitochondrial membrane potential measurement; patient-derived fibroblast analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (biochemical GSH assay, membrane potential measurement, patient cells, KD/OE), single lab","pmids":["21965300"],"is_preprint":false},{"year":2013,"finding":"GDAP1 is also targeted to peroxisomes via the import receptor Pex19. GDAP1 knockdown causes peroxisomal elongation rescuable by re-expressing GDAP1 or CMT missense mutants. Peroxisomal fission by GDAP1 depends on the integrity of its hydrophobic domain 1 (HD1) and on Drp1 and Mff, as does mitochondrial fission. CMT mutations in the N-terminal GDAP1 domains more critically impair mitochondrial fission than peroxisomal fission.","method":"Immunofluorescence co-localization with peroxisomal markers; Pex19 interaction assay; knockdown and rescue experiments; dominant-negative Drp1 and Mff RNAi epistasis; HD1 mutagenesis","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-localization, genetic epistasis, mutagenesis, KD/rescue) in a single focused study","pmids":["23628762"],"is_preprint":false},{"year":2013,"finding":"GDAP1 interacts with the vesicle-organelle trafficking proteins RAB6B and caytaxin. GDAP1 silencing in SH-SY5Y cells causes abnormal mitochondrial distribution, reduces mitochondria-ER contact sites, and impairs mitochondrial mobilization toward the plasma membrane upon ER-Ca2+ depletion. GDAP1 silencing reduces Ca2+ inflow through store-operated Ca2+ entry (SOCE) and SOCE-driven mitochondrial Ca2+ uptake, without affecting mitochondrial Ca2+ uptake per se, ER-Ca2+ levels, or Ca2+ flow from ER to mitochondria.","method":"Co-immunoprecipitation of RAB6B and caytaxin; siRNA knockdown; live-cell Ca2+ imaging; mitochondrial distribution assays; SOCE measurement","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP for binding partners combined with functional SOCE and Ca2+ imaging readouts in same study","pmids":["23542510"],"is_preprint":false},{"year":2014,"finding":"In Gdap1 knockout mice, intra-axonal mitochondria are larger and mitochondrial transport is impaired in cultured sensory neurons. Ablation of Gdap1 in Schwann cells recapitulates the hypomyelinating neuropathy phenotype. Mitochondrial DNA biogenesis and content are increased in the peripheral nervous system but not CNS of Gdap1-/- mice. The GDAP1 paralogue GDAP1L1, mainly expressed in the CNS, translocates from cytosol to mitochondria in response to elevated oxidized glutathione, and this translocation is necessary to compensate for GDAP1 loss.","method":"Gdap1 knockout mouse model; live mitochondrial transport imaging in cultured sensory neurons; Schwann cell-specific Gdap1 ablation; mitochondrial DNA content quantification; GDAP1L1 localization experiments with oxidized glutathione treatment","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse with defined cellular phenotypes, cell-type-specific ablation, and mechanistic follow-up on GDAP1L1 translocation","pmids":["24480485"],"is_preprint":false},{"year":2014,"finding":"Gdap1 knockout mouse motor neurons show large and defective mitochondria, ER cisternae changes, reduced α-tubulin acetylation, increased autophagy vesicles, reduced cytosolic calcium, and reduced SOCE response. These changes are associated with progressive loss of motor neurons and neuromuscular junction defects.","method":"Gdap1 knockout mouse; embryonic motor neuron cultures; electron microscopy; live-cell Ca2+ imaging; SOCE assays; histopathology","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo KO mouse validated with primary neuron cultures and multiple orthogonal readouts","pmids":["25860513"],"is_preprint":false},{"year":2011,"finding":"GDAP1 and human FIS1 are functionally related: GDAP1 complements the G2/M cell cycle delay in S. cerevisiae fis1Δ cells. CMT missense mutations rescue other fis1Δ phenotypes but not the cell cycle delay. GDAP1 physically interacts with β-tubulin (TUBB), and yeast Fis1p interacts with yeast β-tubulin Tub2p, suggesting a conserved interaction between the mitochondrial fission machinery and microtubules.","method":"Yeast complementation assay; cell cycle analysis; Co-immunoprecipitation of GDAP1 with TUBB; CMT mutant rescue experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast complementation plus Co-IP in human cells, single lab, two orthogonal methods","pmids":["21890626"],"is_preprint":false},{"year":2016,"finding":"GDAP1 possesses theta-class-like glutathione S-transferase (GST) enzymatic activity demonstrated with recombinant protein. This GST activity is regulated in an autoinhibitory manner by the C-terminal hydrophobic domain 1 (HD1). The amphipathic pattern of HD1 is required for GDAP1 to induce membrane dynamics (fission). Both fission and GST activities critically depend on HD1, suggesting a molecular switch between pro-fission active and autoinhibited inactive conformations.","method":"Recombinant GDAP1 protein GST activity assay; HD1 domain mutagenesis; mitochondrial fission assay; in vitro biochemistry","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro GST activity assay with mutagenesis plus cellular fission assay, single lab","pmids":["27841286"],"is_preprint":false},{"year":2017,"finding":"CMT recessive loss-of-function mutations in the α-loop of GDAP1 reduce SOCE and SOCE-stimulated mitochondrial respiration in neuroblastoma cells, while dominant mutations do not. GDAP1 silencing or MCU silencing/mitochondrial depolarization (which prevent mitochondrial Ca2+ uptake) both blunt Ca2+-dependent upregulation of respiration after SOCE. Reduced ER-Ca2+ levels are also observed in cells with recessive GDAP1 mutations.","method":"GDAP1 knockdown; CMT mutant expression; SOCE measurement; Seahorse respirometry; MCU silencing epistasis; ER-Ca2+ measurement","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Ca2+ imaging, respirometry, epistasis with MCU), single lab","pmids":["28220846"],"is_preprint":false},{"year":2021,"finding":"GDAP1 participates in basal autophagy and its depletion affects LC3 and PI3P biology in autophagosome biogenesis and membrane trafficking from MAMs. GDAP1 interacts with PIKfyve kinase (a pH-dependent lysosomal regulator) and with LAMP-1, establishing GDAP1-LAMP-1 as a new tethering pair for mitochondria-lysosome membrane contact sites (MCSs). GDAP1 deficiency reduces mitochondria-lysosome MCSs, causes giant lysosomes with hydrolytic activity, delays autophagic lysosome reformation, and activates TFEB. GSH supplementation rescues lysosome membrane defects and mitochondrial network abnormalities but not interorganelle MCSs or early autophagic events.","method":"Co-immunoprecipitation of GDAP1 with LAMP-1 and PIKfyve; siRNA knockdown; live-cell imaging of MCSs; lysosome size/hydrolytic activity assays; TFEB activation assay; GSH rescue experiments in neuronal cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP for LAMP-1 and PIKfyve plus multiple orthogonal functional assays, single lab","pmids":["33372681"],"is_preprint":false},{"year":2022,"finding":"GDAP1 interacts with the actin-depolymerizing protein Cofilin-1 and with β-tubulin in a redox-dependent manner. GDAP1 loss reduces F-actin near mitochondria, restricts mitochondrial localization of the fission factor DRP1, and causes mitochondrial tubularity. GDAP1 silencing also disrupts mitochondria-ER contact sites, lowers mitochondrial Ca2+ levels, and inhibits the pyruvate dehydrogenase complex (PDC), causing glutamine dependence and reduced cytosolic lipid droplets.","method":"Co-immunoprecipitation of GDAP1 with Cofilin-1 and β-tubulin; siRNA knockdown in SH-SY5Y; patient-derived motoneurons; phalloidin F-actin staining; DRP1 localization assay; Seahorse metabolic assay; PDC activity measurement; mitochondria-ER contact site imaging","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP for binding partners plus multiple orthogonal mechanistic readouts (actin, DRP1, PDC, metabolism) across patient-derived and knockdown models","pmids":["35662277"],"is_preprint":false},{"year":2020,"finding":"GDAP1 has lost the ability to bind glutathione despite retaining substrate binding activity in its H-site. The α-loop within the H-site motif is the primary determinant for substrate binding. Critical G-site residues that canonically interact with glutathione are altered in GDAP1. Overexpression of GDAP1 in HeLa cells produces a mitochondrial morphology phenotype distinct from oxidative stress-induced fragmentation; this phenotype depends on the transmembrane domain and a unique hydrophobic domain absent in canonical GSTs.","method":"Biochemical glutathione binding assay with recombinant GDAP1; structural analysis; α-loop mutagenesis; GDAP1 overexpression mitochondrial morphology assay; domain deletion experiments","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted biochemical binding assay plus mutagenesis plus structural analysis, single lab","pmids":["32274853"],"is_preprint":false},{"year":2021,"finding":"Crystal structure of the complete human GDAP1 core domain reveals a novel dimerization mode within the GST family. The long GDAP1-specific insertion forms an extended helix and a flexible loop. GDAP1 is catalytically inactive toward classical GST substrates. A fatty acid ligand (hexadecanedioic acid) binds to a pocket adjacent to a CMT-linked residue cluster, increases protein stability, and induces changes in protein conformation and oligomerization. GDAP1L1 (the closest GDAP1 homologue) is monomeric in full-length form.","method":"X-ray crystallography of human GDAP1 core domain; metabolite screening; GST substrate activity assay; thermal stability assay; analytical ultracentrifugation for oligomeric state","journal":"Frontiers in molecular biosciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus biochemical validation (ligand binding, activity assay, stability), single lab with multiple orthogonal methods","pmids":["33585569"],"is_preprint":false},{"year":2014,"finding":"In Gdap1 knockout embryonic motor neurons, mitochondrial axonal transport is defective, mitochondria show functional membrane abnormalities with reduced ATP production and impaired bioenergetics, and both basal and stimulated (glutamate) cytosolic Ca2+ levels are increased. GDAP1 loss reduces glutamate-stimulated respiration, suggesting that mitochondria cannot fully respond to Ca2+-mediated energy demand.","method":"Gdap1 knockout mouse; live-cell mitochondrial transport imaging in cultured embryonic motor neurons; mitochondrial membrane potential assay; Seahorse respirometry; live Ca2+ imaging with glutamate stimulation","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo KO primary neuron cultures with multiple orthogonal functional readouts (transport, bioenergetics, Ca2+)","pmids":["33582224"],"is_preprint":false},{"year":2009,"finding":"The transcription factor YY1 directly binds a consensus site in the GDAP1 core promoter. YY1 overexpression activates the GDAP1 promoter in a reporter gene system and increases endogenous GDAP1 mRNA. RNAi-mediated YY1 knockdown reduces GDAP1 expression. The regulatory effect is activatory in all cell lines tested.","method":"In vitro binding assay (EMSA); reporter gene (luciferase) assay; YY1 overexpression; YY1 RNAi knockdown with endogenous mRNA measurement","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter assay plus RNAi knockdown, single lab, two orthogonal methods confirming YY1-dependent transcriptional regulation","pmids":["19720140"],"is_preprint":false},{"year":2014,"finding":"Junctophilin-1 (JPH1) can restore SOCE activity in GDAP1-silenced cells. JPH1 colocalizes with STIM1 in ER-plasma membrane puncta during Ca2+ release in a GDAP1-dependent manner. When GDAP1 p.R120W (dominant CMT mutation) is expressed, JPH1 appears retained in mitochondria rather than at ER-plasma membrane puncta. Co-expression of GDAP1 p.R120W and JPH1 p.R213P dramatically reduces SOCE, mimicking GDAP1 knockdown.","method":"GDAP1 siRNA knockdown with JPH1 rescue; SOCE measurement by Ca2+ imaging; co-localization of JPH1 with STIM1 by immunofluorescence; dominant GDAP1 mutant expression","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue assay plus co-localization imaging plus dominant mutant epistasis, single lab","pmids":["25168384"],"is_preprint":false},{"year":2008,"finding":"In fibroblasts from CMT2K patients carrying a dominant GDAP1 C240Y mutation, mitochondrial respiratory chain complex I activity is approximately 40% lower than controls, and mitochondria are 33% larger in diameter with 20% greater mitochondrial mass, suggesting GDAP1 is involved in energy production and mitochondrial volume control.","method":"Patient-derived fibroblasts; spectrophotometric mitochondrial complex I activity assay; morphometric mitochondrial size analysis","journal":"Neurogenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct biochemical assay in patient cells, but single lab, single mutation, no genetic rescue","pmids":["19089472"],"is_preprint":false},{"year":2014,"finding":"Altered expression of Drosophila Gdap1 (confirmed ortholog) produces changes in mitochondrial size, morphology, and distribution in a tissue-autonomous manner in muscle, and causes neuronal and muscular degeneration. Oxidative stress changes are not a primary cause but a long-term consequence of underlying mitochondrial dysfunction.","method":"Tissue-specific Drosophila Gdap1 overexpression and RNAi knockdown; mitochondrial morphology imaging; metabolic analyses; neuronal/muscular degeneration quantification","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Drosophila ortholog model with tissue-specific manipulation and multiple readouts, single lab","pmids":["25122658"],"is_preprint":false},{"year":2011,"finding":"Some CMT mutations in GDAP1 lead to reduced protein expression and cause selective structural disruption of the Golgi apparatus, accompanied by functional disturbances within the Golgi, as detected in both yeast and human cell-based models.","method":"Expression of GDAP1 CMT mutants in yeast and human cells; Golgi morphology imaging; drug screen in yeast-based CMT-GDAP1 model","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method for Golgi involvement (morphology imaging), preliminary functional link","pmids":["33477664"],"is_preprint":false},{"year":2023,"finding":"Using synchrotron radiation oriented circular dichroism and small-angle X-ray scattering on GDAP1 peptides and full-length protein in lipidic environments, GDAP1 is modeled as inserting into the mitochondrial outer membrane via a single transmembrane helix flanked by two peripheral helices that interact with the outer and inner leaflets of the membrane in different orientations.","method":"Synchrotron radiation oriented circular dichroism (OCD) spectroscopy; small-angle X-ray scattering (SAXS) with lipid bilayer systems; structural modeling","journal":"Biophysical chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — structural/biophysical method (OCD + SAXS) providing first experimental model for membrane assembly, single lab, no functional mutagenesis validation","pmids":["37778197"],"is_preprint":false},{"year":2023,"finding":"CMT-linked GDAP1 mutations affecting helices α3, α6, and α7 decrease thermal stability without grossly altering overall protein structure. A conserved intramolecular interaction network centered on the α6-α7 loop is critical for GDAP1 stability. Crystal structures of R120Q, A247V, and R282H variants confirm near-normal fold but reduced stability.","method":"X-ray crystallography of CMT variant proteins (R120Q, A247V, R282H); thermal stability assays (DSF); solution SAXS for R161H, H256R, R310Q, R310W variants; bioinformatics conservation analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple crystal structures plus biophysical stability measurements for multiple CMT variants, single lab","pmids":["37058526"],"is_preprint":false},{"year":2023,"finding":"GDAP1 deficiency (GDAP1-null iPSC-derived motor neurons) causes altered mitochondrial morphology with increased fragmentation, activation of autophagy and mitophagy, downregulation of Hexokinase 2 and ATP5b, increased ROS and elevated mitochondrial membrane potential, and increased innate immune response with p38 MAPK activation, collectively constituting a Redox-inflammatory axis underlying motor neuron degeneration.","method":"Gdap1 knockout iPSC-derived motor neurons; mitochondrial morphology assay; autophagy/mitophagy markers; proteomics (Western blot for HK2, ATP5b); ROS measurement; mitochondrial membrane potential assay; p38 MAPK activation assay; transcriptomic analysis","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — iPSC-KO model with multiple orthogonal readouts, single lab","pmids":["37393339"],"is_preprint":false},{"year":2025,"finding":"GDAP1 knockdown in human neuronal cells increases mitochondrial turnover, biogenesis, and mitophagy, associated with increased BNIP3 and BNIP3L in mitochondrial fractions. Neural expression of human BNIP3 in Drosophila with Gdap1 knockdown reduces detrimental effects on eclosion and climbing, while simultaneous knockdown of both genes is detrimental, suggesting BNIP3-driven mitophagy acts as a partial protective mechanism against GDAP1 loss.","method":"GDAP1 siRNA knockdown in neuronal cell line; mitochondrial fraction proteomics; Drosophila neural Gdap1 knockdown with BNIP3 overexpression or simultaneous knockdown; behavioral assays","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in Drosophila plus proteomics in human cells, two orthogonal approaches, single lab","pmids":["40618856"],"is_preprint":false},{"year":2024,"finding":"GDAP1 deficiency disrupts mitochondria-peroxisome membrane contact sites (MCSs) and causes peroxisomal abnormalities reversible by PPARγ activation or glutathione supplementation. GDAP1 is identified as a tether of mitochondria-peroxisome MCSs. GSH supplementation or GDAP1 overexpression rescues these MCSs. GDAP1 deficiency in Gdap1-/- sciatic nerve causes nodes of Ranvier disruption and abnormal distribution/morphology of mitochondria, lysosomes, and peroxisomes in axons.","method":"High-resolution microscopy and live-cell imaging of MCSs in Gdap1-/- mice and patient fibroblasts; pH-sensitive fluorescent probes; transcriptomics and lipidomics; PPARγ agonist and GSH-MEE rescue experiments; sciatic nerve axon ultrastructure analysis","journal":"Research square (preprint)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple imaging and omics methods plus pharmacological rescue in KO mouse and patient cells, single lab, preprint status","pmids":["39801517"],"is_preprint":true},{"year":2021,"finding":"The dominant GDAP1 p.T157P variant increases mitochondria-lysosome membrane contact sites correlating with hyper-fissioned mitochondria, while the recessive p.R161H variant decreases these contacts with more elongated mitochondria, indicating that GDAP1 clinical variants differentially regulate mitochondria-lysosome MCSs and Ca2+ transfer from lysosome to mitochondria.","method":"Expression of GDAP1 clinical variants in cells; live-cell imaging of mitochondria-lysosome MCSs; mitochondrial morphology assay","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct imaging of MCSs with variant-specific effects across two mutations, single lab","pmids":["36912213"],"is_preprint":false}],"current_model":"GDAP1 is a tail-anchored outer mitochondrial membrane protein with a GST-like fold that acts as a mitochondrial fission factor (dependent on Drp1, Fis1, and Mff), regulates mitochondrial membrane contact sites with the ER, lysosomes, and peroxisomes, controls cellular glutathione levels and redox homeostasis, modulates store-operated Ca2+ entry and Ca2+-stimulated respiration, interacts with Cofilin-1 and β-tubulin to couple actin/cytoskeletal dynamics to mitochondrial DRP1 recruitment and pyruvate dehydrogenase complex activity, and is transcriptionally activated by YY1; recessive CMT mutations reduce fission and impair mitochondrial–ER/lysosome/peroxisome contacts, while dominant mutations disrupt fusion, increase ROS, and alter mitochondria-lysosome contact dynamics, collectively causing axonal bioenergetic and Ca2+ homeostasis defects underlying Charcot-Marie-Tooth neuropathy."},"narrative":{"mechanistic_narrative":"GDAP1 is a tail-anchored outer mitochondrial membrane protein that functions as a fission factor coupling mitochondrial dynamics to redox state, calcium handling, and interorganelle communication in neurons [PMID:19782751, PMID:19340293]. It anchors in the mitochondrial outer membrane through a single transmembrane domain flanked by basic residues and peripheral helices, and these targeting determinants are required for its pro-fission activity [PMID:19340293, PMID:37778197]. GDAP1 drives mitochondrial fission in a manner dependent on Drp1 and Fis1, and additionally localizes to peroxisomes via Pex19 to promote Drp1/Mff-dependent peroxisomal fission, with its hydrophobic domain 1 (HD1) essential for both activities [PMID:19782751, PMID:23628762]. Although GDAP1 adopts a GST-like fold, structural and biochemical work shows it has lost canonical glutathione binding through alterations in G-site residues while retaining H-site substrate binding; HD1 acts as an autoinhibitory switch between fission-active and inactive conformations [PMID:27841286, PMID:32274853, PMID:33585569]. Functionally, GDAP1 raises cellular glutathione and mitochondrial membrane potential, supports store-operated Ca2+ entry (SOCE) and SOCE-stimulated mitochondrial respiration, and organizes membrane contact sites between mitochondria and the ER, lysosomes, and peroxisomes—acting as a LAMP-1 tether for mitochondria-lysosome contacts and a tether for mitochondria-peroxisome contacts [PMID:21965300, PMID:23542510, PMID:28220846, PMID:33372681, PMID:39801517]. It links the actin/microtubule cytoskeleton to mitochondrial fission through redox-dependent interactions with Cofilin-1 and β-tubulin that govern DRP1 recruitment, while also sustaining pyruvate dehydrogenase complex activity and bioenergetic flexibility [PMID:21890626, PMID:35662277]. GDAP1 expression is transcriptionally activated by YY1 [PMID:19720140]. Loss of GDAP1 in mice, iPSC-derived motor neurons, and Drosophila produces enlarged or abnormal mitochondria, impaired axonal mitochondrial transport, bioenergetic and Ca2+ homeostasis defects, and progressive motor and sensory neuron degeneration; recessive mutations impair fission, glutathione elevation, and contact-site formation, whereas dominant mutations disrupt fusion, increase ROS, and alter mitochondria-lysosome contact dynamics, together underlying Charcot-Marie-Tooth neuropathy [PMID:21965300, PMID:24480485, PMID:25860513, PMID:33582224, PMID:25168384, PMID:37393339].","teleology":[{"year":2005,"claim":"Established where GDAP1 acts by showing it is a mitochondrial protein whose C-terminal transmembrane domains determine its localization, anchoring all subsequent mechanism to mitochondria.","evidence":"Overexpression with organelle co-localization, subcellular fractionation, and C-terminal deletion in neuroblastoma and COS-7 cells","pmids":["15772096"],"confidence":"High","gaps":["Did not define molecular function","Membrane topology and anchoring mode unresolved"]},{"year":2009,"claim":"Defined GDAP1's core molecular activity as a Drp1/Fis1-dependent fission factor and distinguished recessive (loss of fission) from dominant (impaired fusion, increased ROS) mutation mechanisms.","evidence":"Overexpression/knockdown, morphology, ROS and apoptosis assays, and dominant-negative epistasis with Drp1 and Fis1 in cell lines","pmids":["19782751"],"confidence":"High","gaps":["Direct biochemical mechanism of fission not shown","How GDAP1 engages the fission machinery undefined"]},{"year":2009,"claim":"Resolved the membrane anchoring requirement by showing GDAP1 is a tail-anchored MOM protein whose TMD plus flanking basic residues are required for both targeting and fission.","evidence":"TMD and flanking-residue mutagenesis with targeting and fission readouts in cell lines","pmids":["19340293"],"confidence":"High","gaps":["Insertion machinery not identified","Did not address peripheral helix contributions"]},{"year":2009,"claim":"Identified the upstream transcriptional control of GDAP1, showing YY1 directly activates its promoter.","evidence":"EMSA, luciferase reporter, and YY1 overexpression/RNAi with endogenous mRNA measurement","pmids":["19720140"],"confidence":"Medium","gaps":["Physiological/neuronal context of YY1 regulation unclear","Other regulators not mapped"]},{"year":2011,"claim":"Linked GDAP1 fission to glutathione and redox homeostasis, connecting morphology to oxidative protection.","evidence":"Overexpression/RNAi in HT22 and NSC34 cells, GSH and membrane potential assays, and CMT4A patient fibroblasts","pmids":["21965300"],"confidence":"High","gaps":["Mechanism by which GDAP1 raises GSH not established","Whether direct enzymatic activity is involved unresolved at this stage"]},{"year":2011,"claim":"Connected GDAP1 to the cytoskeleton and a conserved fission-microtubule axis through functional relatedness to Fis1 and physical β-tubulin interaction.","evidence":"Yeast fis1Δ complementation, cell cycle analysis, and Co-IP of GDAP1 with TUBB","pmids":["21890626"],"confidence":"Medium","gaps":["Functional consequence of β-tubulin binding not demonstrated in this study","Yeast surrogate may not reflect neuronal context"]},{"year":2013,"claim":"Extended GDAP1's fission role to peroxisomes via Pex19 import and showed differential mutation sensitivity between mitochondrial and peroxisomal fission.","evidence":"Peroxisomal co-localization, Pex19 interaction, knockdown/rescue, and Drp1/Mff epistasis with HD1 mutagenesis","pmids":["23628762"],"confidence":"High","gaps":["Why N-terminal mutations preferentially impair mitochondrial fission unexplained"]},{"year":2013,"claim":"Placed GDAP1 at mitochondria-ER contacts and in calcium signaling by linking it to RAB6B/caytaxin, SOCE, and mitochondrial positioning.","evidence":"Co-IP of RAB6B and caytaxin, siRNA knockdown, live-cell Ca2+ imaging and SOCE measurement in SH-SY5Y cells","pmids":["23542510"],"confidence":"High","gaps":["Direct tethering molecules at ER contacts not identified here","Causal chain from contacts to SOCE incomplete"]},{"year":2014,"claim":"Demonstrated in vivo consequences of GDAP1 loss—enlarged mitochondria, impaired axonal transport, Schwann-cell-autonomous neuropathy—and identified GDAP1L1 as a redox-triggered compensatory paralog.","evidence":"Gdap1 knockout mouse, live transport imaging, Schwann-cell-specific ablation, mtDNA quantification, GDAP1L1 translocation assays","pmids":["24480485"],"confidence":"High","gaps":["Molecular trigger for GDAP1L1 translocation undefined","Mechanism of transport defect not resolved"]},{"year":2014,"claim":"Connected GDAP1 loss to motor neuron bioenergetic failure and Ca2+ dysregulation, tying organelle defects to functional decline.","evidence":"Gdap1 KO motor neurons with EM, Ca2+ imaging, SOCE assays, respirometry and histopathology","pmids":["25860513","33582224"],"confidence":"High","gaps":["Primary lesion versus secondary consequence not fully separated","Cell-type selectivity of degeneration unexplained"]},{"year":2014,"claim":"Identified JPH1 as a functional partner restoring SOCE in GDAP1-deficient cells and showed dominant mutant retains JPH1 at mitochondria.","evidence":"JPH1 rescue of SOCE, STIM1 co-localization, and dominant p.R120W mutant expression","pmids":["25168384"],"confidence":"Medium","gaps":["Direct GDAP1-JPH1 physical interaction not shown","Single-lab functional model"]},{"year":2014,"claim":"Confirmed conserved organismal function via Drosophila ortholog and established that oxidative stress is a consequence rather than primary cause of mitochondrial dysfunction.","evidence":"Tissue-specific Drosophila Gdap1 overexpression/RNAi with morphology, metabolic and degeneration readouts","pmids":["25122658"],"confidence":"Medium","gaps":["Molecular ordering of dysfunction vs ROS not biochemically dissected"]},{"year":2016,"claim":"Provided the first enzymatic and conformational model: GDAP1 has theta-class-like GST activity gated by an autoinhibitory HD1 acting as a fission/enzyme molecular switch.","evidence":"Recombinant GST activity assay, HD1 mutagenesis, and cellular fission assay","pmids":["27841286"],"confidence":"High","gaps":["Physiological substrate not identified","Switch reconciliation with later loss-of-GSH-binding data needed"]},{"year":2017,"claim":"Linked GDAP1 calcium function directly to bioenergetics, showing recessive α-loop mutations blunt SOCE-stimulated respiration via mitochondrial Ca2+ uptake.","evidence":"Knockdown, CMT mutant expression, SOCE, Seahorse respirometry, MCU silencing epistasis and ER-Ca2+ measurement","pmids":["28220846"],"confidence":"High","gaps":["How GDAP1 controls SOCE molecularly remains open","Dominant-versus-recessive divergence mechanism unresolved"]},{"year":2020,"claim":"Revised the enzymatic model by demonstrating GDAP1 has lost glutathione binding while retaining H-site substrate binding, and that morphology effects depend on its unique hydrophobic domain.","evidence":"Recombinant glutathione binding assay, structural analysis, α-loop mutagenesis and overexpression morphology assay","pmids":["32274853"],"confidence":"High","gaps":["True physiological substrate of the retained H-site unknown","Reconciling residual catalytic activity with no GSH binding"]},{"year":2021,"claim":"Provided the crystal structure revealing a GDAP1-specific dimerization mode, catalytic inactivity toward classical GST substrates, and a CMT-cluster-adjacent fatty acid binding pocket.","evidence":"X-ray crystallography, metabolite screening, GST assay, thermal stability and analytical ultracentrifugation","pmids":["33585569"],"confidence":"High","gaps":["Functional role of fatty acid ligand in cells unknown","Significance of oligomerization for fission untested"]},{"year":2021,"claim":"Defined GDAP1 as a mitochondria-lysosome tether (with LAMP-1 and PIKfyve) and placed it in basal autophagy and lysosome reformation.","evidence":"Reciprocal Co-IP of LAMP-1 and PIKfyve, knockdown, MCS and lysosome imaging, TFEB activation and GSH rescue in neuronal cells","pmids":["33372681"],"confidence":"High","gaps":["Direct tethering geometry not structurally defined","GSH-independent contact-site defects mechanism unclear"]},{"year":2021,"claim":"Showed GDAP1 clinical variants differentially remodel mitochondria-lysosome contacts and lysosome-to-mitochondria Ca2+ transfer, distinguishing dominant from recessive effects.","evidence":"Clinical variant expression with live-cell MCS imaging and morphology assays","pmids":["36912213"],"confidence":"Medium","gaps":["Only two variants tested","Causal link to neuropathy phenotype not established"]},{"year":2022,"claim":"Mechanistically connected GDAP1 to cytoskeletal control of DRP1 recruitment and to mitochondrial metabolism via redox-dependent Cofilin-1/β-tubulin interactions and PDC regulation.","evidence":"Co-IP of Cofilin-1 and β-tubulin, knockdown in SH-SY5Y, patient-derived motoneurons, F-actin/DRP1/PDC and metabolic assays","pmids":["35662277"],"confidence":"High","gaps":["Redox signal that gates the interactions not identified","Direct versus indirect PDC regulation unresolved"]},{"year":2023,"claim":"Provided a biophysical membrane-assembly model with a single transmembrane helix and two leaflet-interacting peripheral helices.","evidence":"Synchrotron OCD spectroscopy and SAXS on peptides and full-length protein in lipid systems","pmids":["37778197"],"confidence":"Medium","gaps":["No functional mutagenesis validation of the model","Topology in native mitochondria not confirmed"]},{"year":2023,"claim":"Showed CMT mutations across helices α3/α6/α7 cause destabilization without gross structural change, identifying protein stability loss as a shared disease mechanism.","evidence":"Crystal structures of R120Q, A247V, R282H, DSF stability assays, SAXS and conservation analysis of multiple variants","pmids":["37058526"],"confidence":"High","gaps":["How destabilization translates to functional loss in cells not shown"]},{"year":2023,"claim":"Defined a redox-inflammatory degeneration axis in GDAP1-null motor neurons linking mitochondrial fragmentation, mitophagy, metabolic remodeling, ROS and p38 MAPK activation.","evidence":"Gdap1 KO iPSC-derived motor neurons with morphology, autophagy/mitophagy markers, proteomics, ROS, membrane potential, p38 and transcriptomics","pmids":["37393339"],"confidence":"Medium","gaps":["Causal ordering of redox versus inflammatory events unresolved","Single-lab iPSC model"]},{"year":2024,"claim":"Identified GDAP1 as a mitochondria-peroxisome contact tether whose loss causes peroxisomal abnormalities reversible by PPARγ activation or glutathione supplementation.","evidence":"High-resolution and live-cell MCS imaging in Gdap1-/- mice and patient fibroblasts, omics, and pharmacological rescue (preprint)","pmids":["39801517"],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Direct peroxisomal tethering partner not identified"]},{"year":2025,"claim":"Showed BNIP3-driven mitophagy partially compensates for GDAP1 loss, defining a protective response axis.","evidence":"GDAP1 knockdown with mitochondrial proteomics and Drosophila BNIP3 epistasis with behavioral assays","pmids":["40618856"],"confidence":"Medium","gaps":["Mechanism linking GDAP1 loss to BNIP3 induction unknown","Therapeutic relevance untested"]},{"year":null,"claim":"The physiological substrate of the retained GST-like H-site and the precise molecular mechanism by which GDAP1 nucleates fission and tethers multiple organelles remain unresolved.","evidence":"No timeline study identifies a native catalytic substrate or reconstitutes GDAP1-driven fission/tethering biochemically","pmids":[],"confidence":"Low","gaps":["No native substrate identified","No reconstituted fission/tethering mechanism","Dominant-vs-recessive structural basis incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[9,13,14]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[11,5,25]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[8,12]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[14]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[4,25]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[11,26]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,12]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[1,2,4]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[11,23,24]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3,23]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,17,18]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[10,12,15]}],"complexes":[],"partners":["DRP1","FIS1","MFF","PEX19","RAB6B","TUBB","LAMP1","CFL1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8TB36","full_name":"Ganglioside-induced differentiation-associated protein 1","aliases":[],"length_aa":358,"mass_kda":41.3,"function":"Regulates the mitochondrial network by promoting mitochondrial fission","subcellular_location":"Mitochondrion outer membrane; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q8TB36/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GDAP1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"TOMM20A","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/GDAP1","total_profiled":1310},"omim":[{"mim_id":"609701","title":"N-ACETYLGLUCOSAMINIDASE, ALPHA-; NAGLU","url":"https://www.omim.org/entry/609701"},{"mim_id":"608340","title":"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA","url":"https://www.omim.org/entry/608340"},{"mim_id":"607831","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K","url":"https://www.omim.org/entry/607831"},{"mim_id":"607731","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H","url":"https://www.omim.org/entry/607731"},{"mim_id":"607706","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE","url":"https://www.omim.org/entry/607706"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":39.7}],"url":"https://www.proteinatlas.org/search/GDAP1"},"hgnc":{"alias_symbol":["CMT4","CMT2K"],"prev_symbol":["CMT4A"]},"alphafold":{"accession":"Q8TB36","domains":[{"cath_id":"3.40.30.10","chopping":"24-108","consensus_level":"medium","plddt":96.6078,"start":24,"end":108},{"cath_id":"1.20.1050.10","chopping":"112-162_198-298","consensus_level":"medium","plddt":94.5303,"start":112,"end":298}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TB36","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TB36-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TB36-F1-predicted_aligned_error_v6.png","plddt_mean":87.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GDAP1","jax_strain_url":"https://www.jax.org/strain/search?query=GDAP1"},"sequence":{"accession":"Q8TB36","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TB36.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TB36/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TB36"}},"corpus_meta":[{"pmid":"15772096","id":"PMC_15772096","title":"GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15772096","citation_count":148,"is_preprint":false},{"pmid":"12499475","id":"PMC_12499475","title":"Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy.","date":"2002","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12499475","citation_count":123,"is_preprint":false},{"pmid":"19782751","id":"PMC_19782751","title":"GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance.","date":"2009","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/19782751","citation_count":117,"is_preprint":false},{"pmid":"8268915","id":"PMC_8268915","title":"Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8268915","citation_count":116,"is_preprint":false},{"pmid":"12566285","id":"PMC_12566285","title":"Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy.","date":"2003","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12566285","citation_count":99,"is_preprint":false},{"pmid":"14595091","id":"PMC_14595091","title":"Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes.","date":"2003","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/14595091","citation_count":87,"is_preprint":false},{"pmid":"12821518","id":"PMC_12821518","title":"Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene.","date":"2003","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12821518","citation_count":82,"is_preprint":false},{"pmid":"20849849","id":"PMC_20849849","title":"Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations.","date":"2010","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20849849","citation_count":77,"is_preprint":false},{"pmid":"18812441","id":"PMC_18812441","title":"Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.","date":"2008","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18812441","citation_count":75,"is_preprint":false},{"pmid":"23542510","id":"PMC_23542510","title":"Silencing of the Charcot-Marie-Tooth disease-associated gene GDAP1 induces abnormal mitochondrial distribution and affects Ca2+ homeostasis by reducing store-operated Ca2+ entry.","date":"2013","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/23542510","citation_count":73,"is_preprint":false},{"pmid":"23628762","id":"PMC_23628762","title":"Charcot-Marie-Tooth disease-associated mutants of GDAP1 dissociate its roles in peroxisomal and mitochondrial fission.","date":"2013","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/23628762","citation_count":72,"is_preprint":false},{"pmid":"21753178","id":"PMC_21753178","title":"Dominant GDAP1 mutations cause predominantly mild CMT phenotypes.","date":"2011","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21753178","citation_count":71,"is_preprint":false},{"pmid":"21965300","id":"PMC_21965300","title":"Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21965300","citation_count":70,"is_preprint":false},{"pmid":"25860513","id":"PMC_25860513","title":"Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25860513","citation_count":68,"is_preprint":false},{"pmid":"19089472","id":"PMC_19089472","title":"Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K).","date":"2008","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19089472","citation_count":68,"is_preprint":false},{"pmid":"18021315","id":"PMC_18021315","title":"Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease.","date":"2007","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18021315","citation_count":63,"is_preprint":false},{"pmid":"33372681","id":"PMC_33372681","title":"Mitochondria-lysosome membrane contacts are defective in GDAP1-related Charcot-Marie-Tooth disease.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33372681","citation_count":61,"is_preprint":false},{"pmid":"24480485","id":"PMC_24480485","title":"The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease.","date":"2014","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24480485","citation_count":61,"is_preprint":false},{"pmid":"21199105","id":"PMC_21199105","title":"Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease.","date":"2010","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/21199105","citation_count":54,"is_preprint":false},{"pmid":"12601710","id":"PMC_12601710","title":"CMT4A: identification of a Hispanic GDAP1 founder mutation.","date":"2003","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12601710","citation_count":53,"is_preprint":false},{"pmid":"12707075","id":"PMC_12707075","title":"Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.","date":"2003","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12707075","citation_count":48,"is_preprint":false},{"pmid":"12868504","id":"PMC_12868504","title":"Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene.","date":"2003","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/12868504","citation_count":47,"is_preprint":false},{"pmid":"18231710","id":"PMC_18231710","title":"A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease.","date":"2008","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18231710","citation_count":46,"is_preprint":false},{"pmid":"14561495","id":"PMC_14561495","title":"Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease.","date":"2003","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/14561495","citation_count":44,"is_preprint":false},{"pmid":"20685671","id":"PMC_20685671","title":"The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K.","date":"2010","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20685671","citation_count":42,"is_preprint":false},{"pmid":"25168384","id":"PMC_25168384","title":"Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25168384","citation_count":42,"is_preprint":false},{"pmid":"19340293","id":"PMC_19340293","title":"Targeting and function of the mitochondrial fission factor GDAP1 are dependent on its tail-anchor.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19340293","citation_count":40,"is_preprint":false},{"pmid":"27231023","id":"PMC_27231023","title":"Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).","date":"2016","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/27231023","citation_count":39,"is_preprint":false},{"pmid":"28220846","id":"PMC_28220846","title":"CMT-linked loss-of-function mutations in GDAP1 impair store-operated Ca2+ entry-stimulated respiration.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28220846","citation_count":37,"is_preprint":false},{"pmid":"15019704","id":"PMC_15019704","title":"Vocal cord and diaphragm paralysis, as clinical features of a French family with autosomal recessive Charcot-Marie-Tooth disease, associated with a new mutation in the GDAP1 gene.","date":"2004","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/15019704","citation_count":36,"is_preprint":false},{"pmid":"25122658","id":"PMC_25122658","title":"Mitochondrial defects and neuromuscular degeneration caused by altered expression of Drosophila Gdap1: implications for the Charcot-Marie-Tooth neuropathy.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25122658","citation_count":35,"is_preprint":false},{"pmid":"22546700","id":"PMC_22546700","title":"A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.","date":"2012","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/22546700","citation_count":35,"is_preprint":false},{"pmid":"22200116","id":"PMC_22200116","title":"A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K.","date":"2011","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22200116","citation_count":32,"is_preprint":false},{"pmid":"21890626","id":"PMC_21890626","title":"Charcot-Marie-Tooth-related gene GDAP1 complements cell cycle delay at G2/M phase in Saccharomyces cerevisiae fis1 gene-defective cells.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21890626","citation_count":30,"is_preprint":false},{"pmid":"31271761","id":"PMC_31271761","title":"Neuroinflammation in the pathogenesis of axonal Charcot-Marie-Tooth disease caused by lack of GDAP1.","date":"2019","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31271761","citation_count":30,"is_preprint":false},{"pmid":"27841286","id":"PMC_27841286","title":"Glutathione-conjugating and membrane-remodeling activity of GDAP1 relies on amphipathic C-terminal domain.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27841286","citation_count":29,"is_preprint":false},{"pmid":"23456260","id":"PMC_23456260","title":"Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland.","date":"2013","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/23456260","citation_count":29,"is_preprint":false},{"pmid":"28751717","id":"PMC_28751717","title":"Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28751717","citation_count":27,"is_preprint":false},{"pmid":"37966693","id":"PMC_37966693","title":"Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects.","date":"2023","source":"Journal, genetic engineering & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37966693","citation_count":26,"is_preprint":false},{"pmid":"27128683","id":"PMC_27128683","title":"Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome.","date":"2016","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/27128683","citation_count":26,"is_preprint":false},{"pmid":"15377708","id":"PMC_15377708","title":"A novel mutation of GDAP1 associated with Charcot-Marie-Tooth disease in three Italian families: evidence for a founder effect.","date":"2004","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15377708","citation_count":24,"is_preprint":false},{"pmid":"30669311","id":"PMC_30669311","title":"Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30669311","citation_count":23,"is_preprint":false},{"pmid":"35662277","id":"PMC_35662277","title":"GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35662277","citation_count":23,"is_preprint":false},{"pmid":"19500985","id":"PMC_19500985","title":"Novel mutations in the GDAP1 gene in patients affected with early-onset axonal Charcot-Marie-Tooth type 4A.","date":"2009","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/19500985","citation_count":23,"is_preprint":false},{"pmid":"29694336","id":"PMC_29694336","title":"A role for the GDAP1 gene in the molecular pathogenesis of Charcot‑Marie‑Tooth disease.","date":"2018","source":"Acta neurobiologiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/29694336","citation_count":22,"is_preprint":false},{"pmid":"33582224","id":"PMC_33582224","title":"Mitochondria and calcium defects correlate with axonal dysfunction in GDAP1-related Charcot-Marie-Tooth mouse model.","date":"2021","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/33582224","citation_count":22,"is_preprint":false},{"pmid":"18504680","id":"PMC_18504680","title":"Two novel mutations in the GDAP1 and PRX genes in early onset Charcot-Marie-Tooth syndrome.","date":"2008","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/18504680","citation_count":22,"is_preprint":false},{"pmid":"8530038","id":"PMC_8530038","title":"Physical and genetic mapping of the CMT4A locus and exclusion of PMP-2 as the defect in CMT4A.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8530038","citation_count":21,"is_preprint":false},{"pmid":"26525999","id":"PMC_26525999","title":"GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course.","date":"2015","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/26525999","citation_count":20,"is_preprint":false},{"pmid":"34440148","id":"PMC_34440148","title":"GDAP1 Involvement in Mitochondrial Function and Oxidative Stress, Investigated in a Charcot-Marie-Tooth Model of hiPSCs-Derived Motor Neurons.","date":"2021","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/34440148","citation_count":20,"is_preprint":false},{"pmid":"32274853","id":"PMC_32274853","title":"Structural and functional divergence of GDAP1 from the glutathione S-transferase superfamily.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32274853","citation_count":19,"is_preprint":false},{"pmid":"29372391","id":"PMC_29372391","title":"Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.","date":"2018","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29372391","citation_count":17,"is_preprint":false},{"pmid":"17433678","id":"PMC_17433678","title":"GDAP1 mutations in Czech families with early-onset CMT.","date":"2007","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/17433678","citation_count":17,"is_preprint":false},{"pmid":"20232219","id":"PMC_20232219","title":"L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype.","date":"2010","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20232219","citation_count":16,"is_preprint":false},{"pmid":"28065847","id":"PMC_28065847","title":"A Drosophila model of GDAP1 function reveals the involvement of insulin signalling in the mitochondria-dependent neuromuscular degeneration.","date":"2017","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28065847","citation_count":16,"is_preprint":false},{"pmid":"21365284","id":"PMC_21365284","title":"A new missense GDAP1 mutation disturbing targeting to the mitochondrial membrane causes a severe form of AR-CMT2C disease.","date":"2011","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/21365284","citation_count":16,"is_preprint":false},{"pmid":"31179332","id":"PMC_31179332","title":"Novel GDAP1 Mutation in a Vietnamese Family with Charcot-Marie-Tooth Disease.","date":"2019","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/31179332","citation_count":14,"is_preprint":false},{"pmid":"19720140","id":"PMC_19720140","title":"YY1-dependent transcriptional regulation of the human GDAP1 gene.","date":"2009","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19720140","citation_count":14,"is_preprint":false},{"pmid":"33480199","id":"PMC_33480199","title":"Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GDAP1 Mutations.","date":"2021","source":"Journal of clinical neurology (Seoul, Korea)","url":"https://pubmed.ncbi.nlm.nih.gov/33480199","citation_count":14,"is_preprint":false},{"pmid":"28244113","id":"PMC_28244113","title":"Clinical and mutational spectrum of Japanese patients with Charcot-Marie-Tooth disease caused by GDAP1 variants.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28244113","citation_count":14,"is_preprint":false},{"pmid":"25403865","id":"PMC_25403865","title":"Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease.","date":"2014","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/25403865","citation_count":14,"is_preprint":false},{"pmid":"33477664","id":"PMC_33477664","title":"Mutations in GDAP1 Influence Structure and Function of the Trans-Golgi Network.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33477664","citation_count":13,"is_preprint":false},{"pmid":"32183277","id":"PMC_32183277","title":"Pathogenic Effect of GDAP1 Gene Mutations in a Yeast Model.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32183277","citation_count":12,"is_preprint":false},{"pmid":"33585569","id":"PMC_33585569","title":"Structure of the Complete Dimeric Human GDAP1 Core Domain Provides Insights into Ligand Binding and Clustering of Disease Mutations.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/33585569","citation_count":12,"is_preprint":false},{"pmid":"21692914","id":"PMC_21692914","title":"Two recessive intermediate Charcot-Marie-Tooth patients with GDAP1 mutations.","date":"2011","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/21692914","citation_count":12,"is_preprint":false},{"pmid":"36912213","id":"PMC_36912213","title":"Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites.","date":"2023","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/36912213","citation_count":11,"is_preprint":false},{"pmid":"37393339","id":"PMC_37393339","title":"Rapid degeneration of iPSC-derived motor neurons lacking Gdap1 engages a mitochondrial-sustained innate immune response.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37393339","citation_count":11,"is_preprint":false},{"pmid":"16343542","id":"PMC_16343542","title":"A novel Met116Thr mutation in the GDAP1 gene in a Polish family with the axonal recessive Charcot-Marie-Tooth type 4 disease.","date":"2005","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16343542","citation_count":11,"is_preprint":false},{"pmid":"15944907","id":"PMC_15944907","title":"Autosomal recessive axonal form of Charcot-Marie-Tooth Disease caused by compound heterozygous 3'-splice site and Ser130Cys mutation in the GDAP1 gene.","date":"2005","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/15944907","citation_count":11,"is_preprint":false},{"pmid":"22971097","id":"PMC_22971097","title":"A novel autosomal dominant GDAP1 mutation in an Italian CMT2 family.","date":"2012","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/22971097","citation_count":11,"is_preprint":false},{"pmid":"25337607","id":"PMC_25337607","title":"A severe recessive and a mild dominant form of Charcot-Marie-Tooth disease associated with a newly identified Glu222Lys GDAP1 gene mutation.","date":"2014","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/25337607","citation_count":10,"is_preprint":false},{"pmid":"9933296","id":"PMC_9933296","title":"Fine localization of the CMT4A locus using a PAC contig and haplotype analysis.","date":"1998","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/9933296","citation_count":10,"is_preprint":false},{"pmid":"18421898","id":"PMC_18421898","title":"Charcot-Marie-Tooth disease type 4C4 caused by a novel Pro153Leu substitution in the GDAP1 gene.","date":"2007","source":"Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology","url":"https://pubmed.ncbi.nlm.nih.gov/18421898","citation_count":10,"is_preprint":false},{"pmid":"18062449","id":"PMC_18062449","title":"A novel GDAP1 mutation P78L responsible for CMT4A disease in three Moroccan families.","date":"2007","source":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","url":"https://pubmed.ncbi.nlm.nih.gov/18062449","citation_count":9,"is_preprint":false},{"pmid":"26648837","id":"PMC_26648837","title":"Mitochondrial Dysfunction in a Patient with 8q21.11 Deletion and Charcot-Marie-Tooth Disease Type 2K due to GDAP1 Haploinsufficiency.","date":"2015","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/26648837","citation_count":9,"is_preprint":false},{"pmid":"37513945","id":"PMC_37513945","title":"Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot-Marie-Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene.","date":"2023","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37513945","citation_count":8,"is_preprint":false},{"pmid":"17001820","id":"PMC_17001820","title":"A novel GDAP1 mutation 439delA is associated with autosomal recessive CMT disease.","date":"2006","source":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","url":"https://pubmed.ncbi.nlm.nih.gov/17001820","citation_count":8,"is_preprint":false},{"pmid":"35153971","id":"PMC_35153971","title":"One PMP22/MPZ and Three MFN2/GDAP1 Concomitant Variants Occurred in a Cohort of 189 Chinese Charcot-Marie-Tooth Families.","date":"2022","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35153971","citation_count":8,"is_preprint":false},{"pmid":"17039978","id":"PMC_17039978","title":"Early onset Charcot-Marie-Tooth disease caused by a homozygous Leu239Phe mutation in the GDAP1 gene.","date":"2006","source":"Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology","url":"https://pubmed.ncbi.nlm.nih.gov/17039978","citation_count":8,"is_preprint":false},{"pmid":"19381883","id":"PMC_19381883","title":"Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).","date":"2009","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19381883","citation_count":7,"is_preprint":false},{"pmid":"32438208","id":"PMC_32438208","title":"Cigarette smoke exposure has region-specific effects on GDAP1 expression in mouse hippocampus.","date":"2020","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/32438208","citation_count":7,"is_preprint":false},{"pmid":"18492089","id":"PMC_18492089","title":"A novel mutation in the GDAP1 gene is associated with autosomal recessive Charcot-Marie-Tooth disease in an Amish family.","date":"2008","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18492089","citation_count":7,"is_preprint":false},{"pmid":"32897397","id":"PMC_32897397","title":"Deep geno- and phenotyping in two consanguineous families with CMT2 reveals HADHA as an unusual disease-causing gene and an intronic variant in GDAP1 as an unusual mutation.","date":"2020","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32897397","citation_count":7,"is_preprint":false},{"pmid":"18991200","id":"PMC_18991200","title":"Clinical, electrophysiological and genetic studies of two families with mutations in the GDAP1 gene.","date":"2008","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/18991200","citation_count":7,"is_preprint":false},{"pmid":"33903021","id":"PMC_33903021","title":"GDAP1 mutations are frequent among Brazilian patients with autosomal recessive axonal Charcot-Marie-Tooth disease.","date":"2021","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/33903021","citation_count":6,"is_preprint":false},{"pmid":"33136338","id":"PMC_33136338","title":"Identification and functional characterization of novel GDAP1 variants in Chinese patients with Charcot-Marie-Tooth disease.","date":"2020","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33136338","citation_count":6,"is_preprint":false},{"pmid":"28236508","id":"PMC_28236508","title":"Phenotypical features of a new dominant GDAP1 pathogenic variant (p.R226del) in axonal Charcot-Marie-Tooth disease.","date":"2017","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/28236508","citation_count":6,"is_preprint":false},{"pmid":"29396836","id":"PMC_29396836","title":"WES homozygosity mapping in a recessive form of Charcot-Marie-Tooth neuropathy reveals intronic GDAP1 variant leading to a premature stop codon.","date":"2018","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/29396836","citation_count":6,"is_preprint":false},{"pmid":"37058526","id":"PMC_37058526","title":"Conserved intramolecular networks in GDAP1 are closely connected to CMT-linked mutations and protein stability.","date":"2023","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/37058526","citation_count":5,"is_preprint":false},{"pmid":"35509130","id":"PMC_35509130","title":"Structural insights into Charcot-Marie-Tooth disease-linked mutations in human GDAP1.","date":"2022","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/35509130","citation_count":5,"is_preprint":false},{"pmid":"28395795","id":"PMC_28395795","title":"Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene.","date":"2016","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28395795","citation_count":5,"is_preprint":false},{"pmid":"36140714","id":"PMC_36140714","title":"The GDAP1 p.Glu222Lys Variant-Weak Pathogenic Effect, Cumulative Effect of Weak Sequence Variants, or Synergy of Both Factors?","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36140714","citation_count":4,"is_preprint":false},{"pmid":"28837237","id":"PMC_28837237","title":"Pseudodominant inheritance pattern in a family with CMT2 caused by GDAP1 mutations.","date":"2017","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/28837237","citation_count":4,"is_preprint":false},{"pmid":"39801517","id":"PMC_39801517","title":"Abnormal redox balance at membrane contact sites causes axonopathy in GDAP1-related Charcot-Marie-Tooth disease.","date":"2024","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/39801517","citation_count":3,"is_preprint":false},{"pmid":"26848201","id":"PMC_26848201","title":"Charcot Marie Tooth disease (CMT4A) due to GDAP1 mutation: report of a Colombian family.","date":"2015","source":"Colombia medica (Cali, Colombia)","url":"https://pubmed.ncbi.nlm.nih.gov/26848201","citation_count":3,"is_preprint":false},{"pmid":"37778197","id":"PMC_37778197","title":"Conformational analysis of membrane-proximal segments of GDAP1 in a lipidic environment using synchrotron radiation suggests a mode of assembly at the mitochondrial outer membrane.","date":"2023","source":"Biophysical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37778197","citation_count":3,"is_preprint":false},{"pmid":"34632054","id":"PMC_34632054","title":"Phenotype of Patients With Charcot-Marie-Tooth With the p.His123Arg Mutation in GDAP1 in Northern Finland.","date":"2021","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34632054","citation_count":3,"is_preprint":false},{"pmid":"40618856","id":"PMC_40618856","title":"Increased BNIP3-mediated mitophagy attenuates GDAP1 loss of function - implications for Charcot-Marie-Tooth disease 4A.","date":"2025","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/40618856","citation_count":2,"is_preprint":false},{"pmid":"36353131","id":"PMC_36353131","title":"Autosomal dominant GDAP1 mutation with severe phenotype and respiratory involvement: A case report.","date":"2022","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36353131","citation_count":2,"is_preprint":false},{"pmid":"38705839","id":"PMC_38705839","title":"Genetic and clinical profile of 15 Chinese families with GDAP1-related Charcot-Marie-Tooth disease and identification of H256R as a frequent mutation.","date":"2024","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/38705839","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47418,"output_tokens":7687,"usd":0.128779,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17397,"output_tokens":6766,"usd":0.128068,"stage2_stop_reason":"end_turn"},"total_usd":0.256847,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"GDAP1 protein localizes to mitochondria, and its C-terminal transmembrane domains are necessary for correct mitochondrial localization. Missense mutations do not alter the mitochondrial localization pattern of the wild-type protein.\",\n      \"method\": \"Transient overexpression in human neuroblastoma and COS-7 cells with co-localization using organelle markers; western blot analysis of subcellular fractions with anti-GDAP1 polyclonal antibodies; C-terminal domain deletion experiments\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct subcellular fractionation plus co-localization imaging with domain deletion, replicated across multiple cell lines in the same study\",\n      \"pmids\": [\"15772096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GDAP1 is a mitochondrial fission factor whose fission activity depends on Drp1 and Fis1. Overexpression or knockdown of wild-type GDAP1 does not influence susceptibility to apoptosis. Recessively inherited CMT mutations reduce fission activity, while dominantly inherited mutations interfere with mitochondrial fusion and increase ROS production, uneven mitochondrial transmembrane potentials, and susceptibility to apoptosis.\",\n      \"method\": \"Overexpression and knockdown experiments in cell lines; mitochondrial morphology assays; ROS measurement; apoptosis susceptibility assays; dominant-negative analysis with Drp1 and Fis1 mutants\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (morphology, ROS, apoptosis, epistasis with fission factors) in a single rigorous study\",\n      \"pmids\": [\"19782751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GDAP1 is a tail-anchored mitochondrial outer membrane (MOM) protein. It contains a single transmembrane domain (TMD) that, together with adjacent basic amino acids, is critical for MOM targeting. The basic amino acids bordering the TMD on the cytoplasmic side are required for both MOM targeting and GDAP1-mediated fission. TMD sequence, length, and hydrophobicity per se do not influence fission function if MOM targeting is maintained.\",\n      \"method\": \"Mutagenesis of TMD and flanking basic residues combined with mitochondrial targeting assays and mitochondrial fission functional readouts in cell lines\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with defined functional readouts (targeting + fission), single lab but multiple domain variants tested\",\n      \"pmids\": [\"19340293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Wild-type GDAP1 overexpression increases total cellular glutathione (GSH) content and mitochondrial membrane potential. GDAP1 knockdown increases susceptibility to GSH depletion-mediated oxidative stress. Fibroblasts from CMT4A patients had reduced GDAP1 levels, reduced GSH, and reduced mitochondrial membrane potential. Recessively inherited CMT mutations that reduce fission activity fail to increase GSH or mitochondrial membrane potential.\",\n      \"method\": \"Overexpression and RNAi knockdown in HT22 and NSC34 neuronal cell lines; GSH measurement assay; mitochondrial membrane potential measurement; patient-derived fibroblast analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (biochemical GSH assay, membrane potential measurement, patient cells, KD/OE), single lab\",\n      \"pmids\": [\"21965300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GDAP1 is also targeted to peroxisomes via the import receptor Pex19. GDAP1 knockdown causes peroxisomal elongation rescuable by re-expressing GDAP1 or CMT missense mutants. Peroxisomal fission by GDAP1 depends on the integrity of its hydrophobic domain 1 (HD1) and on Drp1 and Mff, as does mitochondrial fission. CMT mutations in the N-terminal GDAP1 domains more critically impair mitochondrial fission than peroxisomal fission.\",\n      \"method\": \"Immunofluorescence co-localization with peroxisomal markers; Pex19 interaction assay; knockdown and rescue experiments; dominant-negative Drp1 and Mff RNAi epistasis; HD1 mutagenesis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-localization, genetic epistasis, mutagenesis, KD/rescue) in a single focused study\",\n      \"pmids\": [\"23628762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GDAP1 interacts with the vesicle-organelle trafficking proteins RAB6B and caytaxin. GDAP1 silencing in SH-SY5Y cells causes abnormal mitochondrial distribution, reduces mitochondria-ER contact sites, and impairs mitochondrial mobilization toward the plasma membrane upon ER-Ca2+ depletion. GDAP1 silencing reduces Ca2+ inflow through store-operated Ca2+ entry (SOCE) and SOCE-driven mitochondrial Ca2+ uptake, without affecting mitochondrial Ca2+ uptake per se, ER-Ca2+ levels, or Ca2+ flow from ER to mitochondria.\",\n      \"method\": \"Co-immunoprecipitation of RAB6B and caytaxin; siRNA knockdown; live-cell Ca2+ imaging; mitochondrial distribution assays; SOCE measurement\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP for binding partners combined with functional SOCE and Ca2+ imaging readouts in same study\",\n      \"pmids\": [\"23542510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In Gdap1 knockout mice, intra-axonal mitochondria are larger and mitochondrial transport is impaired in cultured sensory neurons. Ablation of Gdap1 in Schwann cells recapitulates the hypomyelinating neuropathy phenotype. Mitochondrial DNA biogenesis and content are increased in the peripheral nervous system but not CNS of Gdap1-/- mice. The GDAP1 paralogue GDAP1L1, mainly expressed in the CNS, translocates from cytosol to mitochondria in response to elevated oxidized glutathione, and this translocation is necessary to compensate for GDAP1 loss.\",\n      \"method\": \"Gdap1 knockout mouse model; live mitochondrial transport imaging in cultured sensory neurons; Schwann cell-specific Gdap1 ablation; mitochondrial DNA content quantification; GDAP1L1 localization experiments with oxidized glutathione treatment\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse with defined cellular phenotypes, cell-type-specific ablation, and mechanistic follow-up on GDAP1L1 translocation\",\n      \"pmids\": [\"24480485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Gdap1 knockout mouse motor neurons show large and defective mitochondria, ER cisternae changes, reduced α-tubulin acetylation, increased autophagy vesicles, reduced cytosolic calcium, and reduced SOCE response. These changes are associated with progressive loss of motor neurons and neuromuscular junction defects.\",\n      \"method\": \"Gdap1 knockout mouse; embryonic motor neuron cultures; electron microscopy; live-cell Ca2+ imaging; SOCE assays; histopathology\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo KO mouse validated with primary neuron cultures and multiple orthogonal readouts\",\n      \"pmids\": [\"25860513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GDAP1 and human FIS1 are functionally related: GDAP1 complements the G2/M cell cycle delay in S. cerevisiae fis1Δ cells. CMT missense mutations rescue other fis1Δ phenotypes but not the cell cycle delay. GDAP1 physically interacts with β-tubulin (TUBB), and yeast Fis1p interacts with yeast β-tubulin Tub2p, suggesting a conserved interaction between the mitochondrial fission machinery and microtubules.\",\n      \"method\": \"Yeast complementation assay; cell cycle analysis; Co-immunoprecipitation of GDAP1 with TUBB; CMT mutant rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast complementation plus Co-IP in human cells, single lab, two orthogonal methods\",\n      \"pmids\": [\"21890626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GDAP1 possesses theta-class-like glutathione S-transferase (GST) enzymatic activity demonstrated with recombinant protein. This GST activity is regulated in an autoinhibitory manner by the C-terminal hydrophobic domain 1 (HD1). The amphipathic pattern of HD1 is required for GDAP1 to induce membrane dynamics (fission). Both fission and GST activities critically depend on HD1, suggesting a molecular switch between pro-fission active and autoinhibited inactive conformations.\",\n      \"method\": \"Recombinant GDAP1 protein GST activity assay; HD1 domain mutagenesis; mitochondrial fission assay; in vitro biochemistry\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro GST activity assay with mutagenesis plus cellular fission assay, single lab\",\n      \"pmids\": [\"27841286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CMT recessive loss-of-function mutations in the α-loop of GDAP1 reduce SOCE and SOCE-stimulated mitochondrial respiration in neuroblastoma cells, while dominant mutations do not. GDAP1 silencing or MCU silencing/mitochondrial depolarization (which prevent mitochondrial Ca2+ uptake) both blunt Ca2+-dependent upregulation of respiration after SOCE. Reduced ER-Ca2+ levels are also observed in cells with recessive GDAP1 mutations.\",\n      \"method\": \"GDAP1 knockdown; CMT mutant expression; SOCE measurement; Seahorse respirometry; MCU silencing epistasis; ER-Ca2+ measurement\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Ca2+ imaging, respirometry, epistasis with MCU), single lab\",\n      \"pmids\": [\"28220846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GDAP1 participates in basal autophagy and its depletion affects LC3 and PI3P biology in autophagosome biogenesis and membrane trafficking from MAMs. GDAP1 interacts with PIKfyve kinase (a pH-dependent lysosomal regulator) and with LAMP-1, establishing GDAP1-LAMP-1 as a new tethering pair for mitochondria-lysosome membrane contact sites (MCSs). GDAP1 deficiency reduces mitochondria-lysosome MCSs, causes giant lysosomes with hydrolytic activity, delays autophagic lysosome reformation, and activates TFEB. GSH supplementation rescues lysosome membrane defects and mitochondrial network abnormalities but not interorganelle MCSs or early autophagic events.\",\n      \"method\": \"Co-immunoprecipitation of GDAP1 with LAMP-1 and PIKfyve; siRNA knockdown; live-cell imaging of MCSs; lysosome size/hydrolytic activity assays; TFEB activation assay; GSH rescue experiments in neuronal cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP for LAMP-1 and PIKfyve plus multiple orthogonal functional assays, single lab\",\n      \"pmids\": [\"33372681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GDAP1 interacts with the actin-depolymerizing protein Cofilin-1 and with β-tubulin in a redox-dependent manner. GDAP1 loss reduces F-actin near mitochondria, restricts mitochondrial localization of the fission factor DRP1, and causes mitochondrial tubularity. GDAP1 silencing also disrupts mitochondria-ER contact sites, lowers mitochondrial Ca2+ levels, and inhibits the pyruvate dehydrogenase complex (PDC), causing glutamine dependence and reduced cytosolic lipid droplets.\",\n      \"method\": \"Co-immunoprecipitation of GDAP1 with Cofilin-1 and β-tubulin; siRNA knockdown in SH-SY5Y; patient-derived motoneurons; phalloidin F-actin staining; DRP1 localization assay; Seahorse metabolic assay; PDC activity measurement; mitochondria-ER contact site imaging\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP for binding partners plus multiple orthogonal mechanistic readouts (actin, DRP1, PDC, metabolism) across patient-derived and knockdown models\",\n      \"pmids\": [\"35662277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GDAP1 has lost the ability to bind glutathione despite retaining substrate binding activity in its H-site. The α-loop within the H-site motif is the primary determinant for substrate binding. Critical G-site residues that canonically interact with glutathione are altered in GDAP1. Overexpression of GDAP1 in HeLa cells produces a mitochondrial morphology phenotype distinct from oxidative stress-induced fragmentation; this phenotype depends on the transmembrane domain and a unique hydrophobic domain absent in canonical GSTs.\",\n      \"method\": \"Biochemical glutathione binding assay with recombinant GDAP1; structural analysis; α-loop mutagenesis; GDAP1 overexpression mitochondrial morphology assay; domain deletion experiments\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted biochemical binding assay plus mutagenesis plus structural analysis, single lab\",\n      \"pmids\": [\"32274853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Crystal structure of the complete human GDAP1 core domain reveals a novel dimerization mode within the GST family. The long GDAP1-specific insertion forms an extended helix and a flexible loop. GDAP1 is catalytically inactive toward classical GST substrates. A fatty acid ligand (hexadecanedioic acid) binds to a pocket adjacent to a CMT-linked residue cluster, increases protein stability, and induces changes in protein conformation and oligomerization. GDAP1L1 (the closest GDAP1 homologue) is monomeric in full-length form.\",\n      \"method\": \"X-ray crystallography of human GDAP1 core domain; metabolite screening; GST substrate activity assay; thermal stability assay; analytical ultracentrifugation for oligomeric state\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus biochemical validation (ligand binding, activity assay, stability), single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33585569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In Gdap1 knockout embryonic motor neurons, mitochondrial axonal transport is defective, mitochondria show functional membrane abnormalities with reduced ATP production and impaired bioenergetics, and both basal and stimulated (glutamate) cytosolic Ca2+ levels are increased. GDAP1 loss reduces glutamate-stimulated respiration, suggesting that mitochondria cannot fully respond to Ca2+-mediated energy demand.\",\n      \"method\": \"Gdap1 knockout mouse; live-cell mitochondrial transport imaging in cultured embryonic motor neurons; mitochondrial membrane potential assay; Seahorse respirometry; live Ca2+ imaging with glutamate stimulation\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo KO primary neuron cultures with multiple orthogonal functional readouts (transport, bioenergetics, Ca2+)\",\n      \"pmids\": [\"33582224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The transcription factor YY1 directly binds a consensus site in the GDAP1 core promoter. YY1 overexpression activates the GDAP1 promoter in a reporter gene system and increases endogenous GDAP1 mRNA. RNAi-mediated YY1 knockdown reduces GDAP1 expression. The regulatory effect is activatory in all cell lines tested.\",\n      \"method\": \"In vitro binding assay (EMSA); reporter gene (luciferase) assay; YY1 overexpression; YY1 RNAi knockdown with endogenous mRNA measurement\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter assay plus RNAi knockdown, single lab, two orthogonal methods confirming YY1-dependent transcriptional regulation\",\n      \"pmids\": [\"19720140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Junctophilin-1 (JPH1) can restore SOCE activity in GDAP1-silenced cells. JPH1 colocalizes with STIM1 in ER-plasma membrane puncta during Ca2+ release in a GDAP1-dependent manner. When GDAP1 p.R120W (dominant CMT mutation) is expressed, JPH1 appears retained in mitochondria rather than at ER-plasma membrane puncta. Co-expression of GDAP1 p.R120W and JPH1 p.R213P dramatically reduces SOCE, mimicking GDAP1 knockdown.\",\n      \"method\": \"GDAP1 siRNA knockdown with JPH1 rescue; SOCE measurement by Ca2+ imaging; co-localization of JPH1 with STIM1 by immunofluorescence; dominant GDAP1 mutant expression\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue assay plus co-localization imaging plus dominant mutant epistasis, single lab\",\n      \"pmids\": [\"25168384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In fibroblasts from CMT2K patients carrying a dominant GDAP1 C240Y mutation, mitochondrial respiratory chain complex I activity is approximately 40% lower than controls, and mitochondria are 33% larger in diameter with 20% greater mitochondrial mass, suggesting GDAP1 is involved in energy production and mitochondrial volume control.\",\n      \"method\": \"Patient-derived fibroblasts; spectrophotometric mitochondrial complex I activity assay; morphometric mitochondrial size analysis\",\n      \"journal\": \"Neurogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct biochemical assay in patient cells, but single lab, single mutation, no genetic rescue\",\n      \"pmids\": [\"19089472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Altered expression of Drosophila Gdap1 (confirmed ortholog) produces changes in mitochondrial size, morphology, and distribution in a tissue-autonomous manner in muscle, and causes neuronal and muscular degeneration. Oxidative stress changes are not a primary cause but a long-term consequence of underlying mitochondrial dysfunction.\",\n      \"method\": \"Tissue-specific Drosophila Gdap1 overexpression and RNAi knockdown; mitochondrial morphology imaging; metabolic analyses; neuronal/muscular degeneration quantification\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Drosophila ortholog model with tissue-specific manipulation and multiple readouts, single lab\",\n      \"pmids\": [\"25122658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Some CMT mutations in GDAP1 lead to reduced protein expression and cause selective structural disruption of the Golgi apparatus, accompanied by functional disturbances within the Golgi, as detected in both yeast and human cell-based models.\",\n      \"method\": \"Expression of GDAP1 CMT mutants in yeast and human cells; Golgi morphology imaging; drug screen in yeast-based CMT-GDAP1 model\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method for Golgi involvement (morphology imaging), preliminary functional link\",\n      \"pmids\": [\"33477664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Using synchrotron radiation oriented circular dichroism and small-angle X-ray scattering on GDAP1 peptides and full-length protein in lipidic environments, GDAP1 is modeled as inserting into the mitochondrial outer membrane via a single transmembrane helix flanked by two peripheral helices that interact with the outer and inner leaflets of the membrane in different orientations.\",\n      \"method\": \"Synchrotron radiation oriented circular dichroism (OCD) spectroscopy; small-angle X-ray scattering (SAXS) with lipid bilayer systems; structural modeling\",\n      \"journal\": \"Biophysical chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — structural/biophysical method (OCD + SAXS) providing first experimental model for membrane assembly, single lab, no functional mutagenesis validation\",\n      \"pmids\": [\"37778197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CMT-linked GDAP1 mutations affecting helices α3, α6, and α7 decrease thermal stability without grossly altering overall protein structure. A conserved intramolecular interaction network centered on the α6-α7 loop is critical for GDAP1 stability. Crystal structures of R120Q, A247V, and R282H variants confirm near-normal fold but reduced stability.\",\n      \"method\": \"X-ray crystallography of CMT variant proteins (R120Q, A247V, R282H); thermal stability assays (DSF); solution SAXS for R161H, H256R, R310Q, R310W variants; bioinformatics conservation analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple crystal structures plus biophysical stability measurements for multiple CMT variants, single lab\",\n      \"pmids\": [\"37058526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GDAP1 deficiency (GDAP1-null iPSC-derived motor neurons) causes altered mitochondrial morphology with increased fragmentation, activation of autophagy and mitophagy, downregulation of Hexokinase 2 and ATP5b, increased ROS and elevated mitochondrial membrane potential, and increased innate immune response with p38 MAPK activation, collectively constituting a Redox-inflammatory axis underlying motor neuron degeneration.\",\n      \"method\": \"Gdap1 knockout iPSC-derived motor neurons; mitochondrial morphology assay; autophagy/mitophagy markers; proteomics (Western blot for HK2, ATP5b); ROS measurement; mitochondrial membrane potential assay; p38 MAPK activation assay; transcriptomic analysis\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — iPSC-KO model with multiple orthogonal readouts, single lab\",\n      \"pmids\": [\"37393339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GDAP1 knockdown in human neuronal cells increases mitochondrial turnover, biogenesis, and mitophagy, associated with increased BNIP3 and BNIP3L in mitochondrial fractions. Neural expression of human BNIP3 in Drosophila with Gdap1 knockdown reduces detrimental effects on eclosion and climbing, while simultaneous knockdown of both genes is detrimental, suggesting BNIP3-driven mitophagy acts as a partial protective mechanism against GDAP1 loss.\",\n      \"method\": \"GDAP1 siRNA knockdown in neuronal cell line; mitochondrial fraction proteomics; Drosophila neural Gdap1 knockdown with BNIP3 overexpression or simultaneous knockdown; behavioral assays\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in Drosophila plus proteomics in human cells, two orthogonal approaches, single lab\",\n      \"pmids\": [\"40618856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GDAP1 deficiency disrupts mitochondria-peroxisome membrane contact sites (MCSs) and causes peroxisomal abnormalities reversible by PPARγ activation or glutathione supplementation. GDAP1 is identified as a tether of mitochondria-peroxisome MCSs. GSH supplementation or GDAP1 overexpression rescues these MCSs. GDAP1 deficiency in Gdap1-/- sciatic nerve causes nodes of Ranvier disruption and abnormal distribution/morphology of mitochondria, lysosomes, and peroxisomes in axons.\",\n      \"method\": \"High-resolution microscopy and live-cell imaging of MCSs in Gdap1-/- mice and patient fibroblasts; pH-sensitive fluorescent probes; transcriptomics and lipidomics; PPARγ agonist and GSH-MEE rescue experiments; sciatic nerve axon ultrastructure analysis\",\n      \"journal\": \"Research square (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple imaging and omics methods plus pharmacological rescue in KO mouse and patient cells, single lab, preprint status\",\n      \"pmids\": [\"39801517\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The dominant GDAP1 p.T157P variant increases mitochondria-lysosome membrane contact sites correlating with hyper-fissioned mitochondria, while the recessive p.R161H variant decreases these contacts with more elongated mitochondria, indicating that GDAP1 clinical variants differentially regulate mitochondria-lysosome MCSs and Ca2+ transfer from lysosome to mitochondria.\",\n      \"method\": \"Expression of GDAP1 clinical variants in cells; live-cell imaging of mitochondria-lysosome MCSs; mitochondrial morphology assay\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct imaging of MCSs with variant-specific effects across two mutations, single lab\",\n      \"pmids\": [\"36912213\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GDAP1 is a tail-anchored outer mitochondrial membrane protein with a GST-like fold that acts as a mitochondrial fission factor (dependent on Drp1, Fis1, and Mff), regulates mitochondrial membrane contact sites with the ER, lysosomes, and peroxisomes, controls cellular glutathione levels and redox homeostasis, modulates store-operated Ca2+ entry and Ca2+-stimulated respiration, interacts with Cofilin-1 and β-tubulin to couple actin/cytoskeletal dynamics to mitochondrial DRP1 recruitment and pyruvate dehydrogenase complex activity, and is transcriptionally activated by YY1; recessive CMT mutations reduce fission and impair mitochondrial–ER/lysosome/peroxisome contacts, while dominant mutations disrupt fusion, increase ROS, and alter mitochondria-lysosome contact dynamics, collectively causing axonal bioenergetic and Ca2+ homeostasis defects underlying Charcot-Marie-Tooth neuropathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GDAP1 is a tail-anchored outer mitochondrial membrane protein that functions as a fission factor coupling mitochondrial dynamics to redox state, calcium handling, and interorganelle communication in neurons [#1, #2]. It anchors in the mitochondrial outer membrane through a single transmembrane domain flanked by basic residues and peripheral helices, and these targeting determinants are required for its pro-fission activity [#2, #21]. GDAP1 drives mitochondrial fission in a manner dependent on Drp1 and Fis1, and additionally localizes to peroxisomes via Pex19 to promote Drp1/Mff-dependent peroxisomal fission, with its hydrophobic domain 1 (HD1) essential for both activities [#1, #4]. Although GDAP1 adopts a GST-like fold, structural and biochemical work shows it has lost canonical glutathione binding through alterations in G-site residues while retaining H-site substrate binding; HD1 acts as an autoinhibitory switch between fission-active and inactive conformations [#9, #13, #14]. Functionally, GDAP1 raises cellular glutathione and mitochondrial membrane potential, supports store-operated Ca2+ entry (SOCE) and SOCE-stimulated mitochondrial respiration, and organizes membrane contact sites between mitochondria and the ER, lysosomes, and peroxisomes—acting as a LAMP-1 tether for mitochondria-lysosome contacts and a tether for mitochondria-peroxisome contacts [#3, #5, #10, #11, #25]. It links the actin/microtubule cytoskeleton to mitochondrial fission through redox-dependent interactions with Cofilin-1 and β-tubulin that govern DRP1 recruitment, while also sustaining pyruvate dehydrogenase complex activity and bioenergetic flexibility [#8, #12]. GDAP1 expression is transcriptionally activated by YY1 [#16]. Loss of GDAP1 in mice, iPSC-derived motor neurons, and Drosophila produces enlarged or abnormal mitochondria, impaired axonal mitochondrial transport, bioenergetic and Ca2+ homeostasis defects, and progressive motor and sensory neuron degeneration; recessive mutations impair fission, glutathione elevation, and contact-site formation, whereas dominant mutations disrupt fusion, increase ROS, and alter mitochondria-lysosome contact dynamics, together underlying Charcot-Marie-Tooth neuropathy [#3, #6, #7, #15, #17, #23].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established where GDAP1 acts by showing it is a mitochondrial protein whose C-terminal transmembrane domains determine its localization, anchoring all subsequent mechanism to mitochondria.\",\n      \"evidence\": \"Overexpression with organelle co-localization, subcellular fractionation, and C-terminal deletion in neuroblastoma and COS-7 cells\",\n      \"pmids\": [\"15772096\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define molecular function\", \"Membrane topology and anchoring mode unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined GDAP1's core molecular activity as a Drp1/Fis1-dependent fission factor and distinguished recessive (loss of fission) from dominant (impaired fusion, increased ROS) mutation mechanisms.\",\n      \"evidence\": \"Overexpression/knockdown, morphology, ROS and apoptosis assays, and dominant-negative epistasis with Drp1 and Fis1 in cell lines\",\n      \"pmids\": [\"19782751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical mechanism of fission not shown\", \"How GDAP1 engages the fission machinery undefined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved the membrane anchoring requirement by showing GDAP1 is a tail-anchored MOM protein whose TMD plus flanking basic residues are required for both targeting and fission.\",\n      \"evidence\": \"TMD and flanking-residue mutagenesis with targeting and fission readouts in cell lines\",\n      \"pmids\": [\"19340293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Insertion machinery not identified\", \"Did not address peripheral helix contributions\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified the upstream transcriptional control of GDAP1, showing YY1 directly activates its promoter.\",\n      \"evidence\": \"EMSA, luciferase reporter, and YY1 overexpression/RNAi with endogenous mRNA measurement\",\n      \"pmids\": [\"19720140\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological/neuronal context of YY1 regulation unclear\", \"Other regulators not mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked GDAP1 fission to glutathione and redox homeostasis, connecting morphology to oxidative protection.\",\n      \"evidence\": \"Overexpression/RNAi in HT22 and NSC34 cells, GSH and membrane potential assays, and CMT4A patient fibroblasts\",\n      \"pmids\": [\"21965300\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which GDAP1 raises GSH not established\", \"Whether direct enzymatic activity is involved unresolved at this stage\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected GDAP1 to the cytoskeleton and a conserved fission-microtubule axis through functional relatedness to Fis1 and physical β-tubulin interaction.\",\n      \"evidence\": \"Yeast fis1Δ complementation, cell cycle analysis, and Co-IP of GDAP1 with TUBB\",\n      \"pmids\": [\"21890626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of β-tubulin binding not demonstrated in this study\", \"Yeast surrogate may not reflect neuronal context\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended GDAP1's fission role to peroxisomes via Pex19 import and showed differential mutation sensitivity between mitochondrial and peroxisomal fission.\",\n      \"evidence\": \"Peroxisomal co-localization, Pex19 interaction, knockdown/rescue, and Drp1/Mff epistasis with HD1 mutagenesis\",\n      \"pmids\": [\"23628762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why N-terminal mutations preferentially impair mitochondrial fission unexplained\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed GDAP1 at mitochondria-ER contacts and in calcium signaling by linking it to RAB6B/caytaxin, SOCE, and mitochondrial positioning.\",\n      \"evidence\": \"Co-IP of RAB6B and caytaxin, siRNA knockdown, live-cell Ca2+ imaging and SOCE measurement in SH-SY5Y cells\",\n      \"pmids\": [\"23542510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct tethering molecules at ER contacts not identified here\", \"Causal chain from contacts to SOCE incomplete\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated in vivo consequences of GDAP1 loss—enlarged mitochondria, impaired axonal transport, Schwann-cell-autonomous neuropathy—and identified GDAP1L1 as a redox-triggered compensatory paralog.\",\n      \"evidence\": \"Gdap1 knockout mouse, live transport imaging, Schwann-cell-specific ablation, mtDNA quantification, GDAP1L1 translocation assays\",\n      \"pmids\": [\"24480485\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trigger for GDAP1L1 translocation undefined\", \"Mechanism of transport defect not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected GDAP1 loss to motor neuron bioenergetic failure and Ca2+ dysregulation, tying organelle defects to functional decline.\",\n      \"evidence\": \"Gdap1 KO motor neurons with EM, Ca2+ imaging, SOCE assays, respirometry and histopathology\",\n      \"pmids\": [\"25860513\", \"33582224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Primary lesion versus secondary consequence not fully separated\", \"Cell-type selectivity of degeneration unexplained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified JPH1 as a functional partner restoring SOCE in GDAP1-deficient cells and showed dominant mutant retains JPH1 at mitochondria.\",\n      \"evidence\": \"JPH1 rescue of SOCE, STIM1 co-localization, and dominant p.R120W mutant expression\",\n      \"pmids\": [\"25168384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct GDAP1-JPH1 physical interaction not shown\", \"Single-lab functional model\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Confirmed conserved organismal function via Drosophila ortholog and established that oxidative stress is a consequence rather than primary cause of mitochondrial dysfunction.\",\n      \"evidence\": \"Tissue-specific Drosophila Gdap1 overexpression/RNAi with morphology, metabolic and degeneration readouts\",\n      \"pmids\": [\"25122658\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular ordering of dysfunction vs ROS not biochemically dissected\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided the first enzymatic and conformational model: GDAP1 has theta-class-like GST activity gated by an autoinhibitory HD1 acting as a fission/enzyme molecular switch.\",\n      \"evidence\": \"Recombinant GST activity assay, HD1 mutagenesis, and cellular fission assay\",\n      \"pmids\": [\"27841286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrate not identified\", \"Switch reconciliation with later loss-of-GSH-binding data needed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linked GDAP1 calcium function directly to bioenergetics, showing recessive α-loop mutations blunt SOCE-stimulated respiration via mitochondrial Ca2+ uptake.\",\n      \"evidence\": \"Knockdown, CMT mutant expression, SOCE, Seahorse respirometry, MCU silencing epistasis and ER-Ca2+ measurement\",\n      \"pmids\": [\"28220846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GDAP1 controls SOCE molecularly remains open\", \"Dominant-versus-recessive divergence mechanism unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revised the enzymatic model by demonstrating GDAP1 has lost glutathione binding while retaining H-site substrate binding, and that morphology effects depend on its unique hydrophobic domain.\",\n      \"evidence\": \"Recombinant glutathione binding assay, structural analysis, α-loop mutagenesis and overexpression morphology assay\",\n      \"pmids\": [\"32274853\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"True physiological substrate of the retained H-site unknown\", \"Reconciling residual catalytic activity with no GSH binding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Provided the crystal structure revealing a GDAP1-specific dimerization mode, catalytic inactivity toward classical GST substrates, and a CMT-cluster-adjacent fatty acid binding pocket.\",\n      \"evidence\": \"X-ray crystallography, metabolite screening, GST assay, thermal stability and analytical ultracentrifugation\",\n      \"pmids\": [\"33585569\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of fatty acid ligand in cells unknown\", \"Significance of oligomerization for fission untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined GDAP1 as a mitochondria-lysosome tether (with LAMP-1 and PIKfyve) and placed it in basal autophagy and lysosome reformation.\",\n      \"evidence\": \"Reciprocal Co-IP of LAMP-1 and PIKfyve, knockdown, MCS and lysosome imaging, TFEB activation and GSH rescue in neuronal cells\",\n      \"pmids\": [\"33372681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct tethering geometry not structurally defined\", \"GSH-independent contact-site defects mechanism unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed GDAP1 clinical variants differentially remodel mitochondria-lysosome contacts and lysosome-to-mitochondria Ca2+ transfer, distinguishing dominant from recessive effects.\",\n      \"evidence\": \"Clinical variant expression with live-cell MCS imaging and morphology assays\",\n      \"pmids\": [\"36912213\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only two variants tested\", \"Causal link to neuropathy phenotype not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mechanistically connected GDAP1 to cytoskeletal control of DRP1 recruitment and to mitochondrial metabolism via redox-dependent Cofilin-1/β-tubulin interactions and PDC regulation.\",\n      \"evidence\": \"Co-IP of Cofilin-1 and β-tubulin, knockdown in SH-SY5Y, patient-derived motoneurons, F-actin/DRP1/PDC and metabolic assays\",\n      \"pmids\": [\"35662277\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redox signal that gates the interactions not identified\", \"Direct versus indirect PDC regulation unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided a biophysical membrane-assembly model with a single transmembrane helix and two leaflet-interacting peripheral helices.\",\n      \"evidence\": \"Synchrotron OCD spectroscopy and SAXS on peptides and full-length protein in lipid systems\",\n      \"pmids\": [\"37778197\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional mutagenesis validation of the model\", \"Topology in native mitochondria not confirmed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed CMT mutations across helices α3/α6/α7 cause destabilization without gross structural change, identifying protein stability loss as a shared disease mechanism.\",\n      \"evidence\": \"Crystal structures of R120Q, A247V, R282H, DSF stability assays, SAXS and conservation analysis of multiple variants\",\n      \"pmids\": [\"37058526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How destabilization translates to functional loss in cells not shown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined a redox-inflammatory degeneration axis in GDAP1-null motor neurons linking mitochondrial fragmentation, mitophagy, metabolic remodeling, ROS and p38 MAPK activation.\",\n      \"evidence\": \"Gdap1 KO iPSC-derived motor neurons with morphology, autophagy/mitophagy markers, proteomics, ROS, membrane potential, p38 and transcriptomics\",\n      \"pmids\": [\"37393339\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal ordering of redox versus inflammatory events unresolved\", \"Single-lab iPSC model\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified GDAP1 as a mitochondria-peroxisome contact tether whose loss causes peroxisomal abnormalities reversible by PPARγ activation or glutathione supplementation.\",\n      \"evidence\": \"High-resolution and live-cell MCS imaging in Gdap1-/- mice and patient fibroblasts, omics, and pharmacological rescue (preprint)\",\n      \"pmids\": [\"39801517\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Direct peroxisomal tethering partner not identified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed BNIP3-driven mitophagy partially compensates for GDAP1 loss, defining a protective response axis.\",\n      \"evidence\": \"GDAP1 knockdown with mitochondrial proteomics and Drosophila BNIP3 epistasis with behavioral assays\",\n      \"pmids\": [\"40618856\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking GDAP1 loss to BNIP3 induction unknown\", \"Therapeutic relevance untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The physiological substrate of the retained GST-like H-site and the precise molecular mechanism by which GDAP1 nucleates fission and tethers multiple organelles remain unresolved.\",\n      \"evidence\": \"No timeline study identifies a native catalytic substrate or reconstitutes GDAP1-driven fission/tethering biochemically\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No native substrate identified\", \"No reconstituted fission/tethering mechanism\", \"Dominant-vs-recessive structural basis incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [9, 13, 14]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [11, 5, 25]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [8, 12]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [4, 25]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [11, 26]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [11, 23, 24]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3, 23]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 17, 18]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [10, 12, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"DRP1\", \"FIS1\", \"MFF\", \"PEX19\", \"RAB6B\", \"TUBB\", \"LAMP1\", \"CFL1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}